Global Strategic Investment Solutions LLC Sells 7,691 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

Global Strategic Investment Solutions LLC lessened its position in Orthofix Medical Inc. (NASDAQ:OFIX) by 13.3% during the third quarter, Holdings Channel.com reports. The fund owned 50,000 shares of the medical device company’s stock after selling 7,691 shares during the period. Global Strategic Investment Solutions LLC’s holdings in Orthofix Medical were worth $781,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. bought a new position in Orthofix Medical in the 3rd quarter worth $216,000. Inspire Investing LLC bought a new position in Orthofix Medical in the third quarter worth about $417,000. SG Americas Securities LLC lifted its holdings in Orthofix Medical by 74.0% in the third quarter. SG Americas Securities LLC now owns 17,117 shares of the medical device company’s stock worth $267,000 after buying an additional 7,278 shares during the period. AQR Capital Management LLC boosted its position in Orthofix Medical by 4.4% during the 2nd quarter. AQR Capital Management LLC now owns 31,863 shares of the medical device company’s stock valued at $423,000 after acquiring an additional 1,336 shares in the last quarter. Finally, Armistice Capital LLC grew its holdings in shares of Orthofix Medical by 1.4% during the 2nd quarter. Armistice Capital LLC now owns 3,750,000 shares of the medical device company’s stock worth $49,725,000 after acquiring an additional 50,000 shares during the period. Institutional investors own 89.76% of the company’s stock.

Orthofix Medical Stock Up 3.0 %

Shares of OFIX traded up $0.55 on Thursday, reaching $18.95. The stock had a trading volume of 80,538 shares, compared to its average volume of 323,087. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.13 and a current ratio of 2.48. Orthofix Medical Inc. has a 12-month low of $9.57 and a 12-month high of $19.47. The firm has a market capitalization of $723.42 million, a price-to-earnings ratio of -5.77 and a beta of 1.05. The company has a 50-day simple moving average of $16.18 and a 200-day simple moving average of $15.20.

Orthofix Medical (NASDAQ:OFIX) last issued its quarterly earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. The business had revenue of $198.62 million during the quarter, compared to the consensus estimate of $195.75 million. Sell-side analysts predict that Orthofix Medical Inc. will post -2.13 EPS for the current year.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.